FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079649 [Registered on: 28/01/2025] Trial Registered Prospectively
Last Modified On: 19/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Impact of Concurrent Exercise Training on HbA1c, Lipid Profile, Body Composition, and Quality of Life in Adults with Type 2 Diabetes 
Scientific Title of Study   The effect of concurrent exercise training on Hba1c levels, Lipid Profile, Body Composition and Quality of Life in adults with Type 2 Diabetes. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Yuthika Rao 
Designation  PhD Scholar 
Affiliation  Mahatma Gandhi University of Medical Sciences and Technology, Jaipur 
Address  Cardio Pulmonary Lab, Mahatma Gandhi Physiotherapy College, MGUMST, Jaipur

Jaipur
RAJASTHAN
302022
India 
Phone  9530096172  
Fax    
Email  dryuthikarao@mgumst.org  
 
Details of Contact Person
Scientific Query
 
Name  Dr Madhusudan Tiwari 
Designation  Dean and Principal  
Affiliation  Mahatma Gandhi University of Medical Sciences and Technology, Jaipur 
Address  Dean and Principal Office, Mahatma Gandhi Physiotherapy College, MGUMST, Jaipur

Jaipur
RAJASTHAN
302022
India 
Phone  8290964159  
Fax    
Email  principal.physiotherapy@mgumst.org  
 
Details of Contact Person
Public Query
 
Name  Dr Madhusudan Tiwari 
Designation  Dean and Principal  
Affiliation  Mahatma Gandhi University of Medical Sciences and Technology, Jaipur 
Address  Dean and Principal Office, Mahatma Gandhi Physiotherapy College, MGUMST, Jaipur

Jaipur
RAJASTHAN
302022
India 
Phone  8290964159  
Fax    
Email  principal.physiotherapy@mgumst.org  
 
Source of Monetary or Material Support  
Mahatma Gandhi Physiotherapy College, Mahatma Gandhi University of Medical Sciences and Technology,RIICO Institutional area, sitapura, tonk road, jaipur , Rajasthan,302022 
 
Primary Sponsor  
Name  Dr Yuthika Rao 
Address  6 62 , SFS, Agarwal Farm, Mansarovar, jaipur, Rajasthan,302022 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Madhusudan Tiwari  Mahatma Gandhi Hospital  Mahatma Gandhi Physiotherapy College, Mahatma Gandhi Institute of Medical Sciences and Technology,Sitapura RIICO Institutional Area, Jaipur, Rajasthan
Jaipur
RAJASTHAN 
9530096172

principal.physiotherapy@mgumst.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee ,Mahatma Gandhi Medical College and Hospital MGUMST, Jaipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E119||Type 2 diabetes mellitus without complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Aerobic Training (4 times/week)  Group C Aerobic Training which includes brisk walking for 30 minutes for 2 times per week continuously for 12 weeks 
Intervention  Concurrent Exercises  Group A Resistance Training which is divided into upper limb resistance exercises and lower limb resistance exercises. In Upper Limb Resistance training following are the exercises Biceps Curl Deltoid muscle Shoulder Flexion Abduction and Extension Triceps Triceps kickback Straight Triceps lift Triceps Extension Single scarecrow Lower limb resistance training are as follows Quadriceps Hamstrings Soleus Duration of the exercises is 2 times per week continuously for 12 weeks Aerobic Training which includes brisk walking for 30 minutes for 2 times per week continuously for 12 weeks  
Comparator Agent  Control Group   Group D - Home Program Active control group will provided standard care during their normal clinic visits to a consultant physician prescribing medication and general health education. There will be no specific instructions given or skills taught regarding exercise nor additional information regarding dietary modifications. The control group also had pre and post intervention measurements of all parameters and background physical activity measurements. This group of participants will contacted via telephone once every 2 weeks during the 12-week period and will met in the middle of the intervention (6-7 weeks).  
Intervention  Resistance Training  Group B Resistance Training which is divided into upper limb resistance exercises and lower limb resistance exercises. In Upper Limb Resistance training following are the exercises Biceps Curl Deltoid muscle, Shoulder Flexion Abduction and Extension Triceps, Triceps kickback Straight Triceps lift, Triceps Extension Single scarecrow Lower limb resistance training are as follows Quadriceps Hamstrings Soleus Duration of the exercises is 2 times per week continuously for 12 weeks 
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Both Male & Female with age between 35yearto 65year.
Diagnosed with T2DM within last 10 years.
Blood HbA1c levels between 6.5% to 9.5%.
Patients referred only from Physician will be enrolled in the study.

 
 
ExclusionCriteria 
Details  Patients who refused to participate in the study.
History of significant cardiovascular (ischemic heart disease etc.), respiratory (asthma chronic obstructive pulmonary disease etc.), musculoskeletal diseases (osteoarthritis of major joints etc.). People with cognitive impairment, intellectual disability, or mental illness pregnant women. Advanced diabetes induced end-stage organ damage (vascular, retinopathy, nephropathy, neuropathy, retinal hemorrhage or detachment, history of laser therapy).
Patients who are on injectable (insulin).
Patients on any current supervised exercise training program.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
HbA1c
Lipid Profile
Body Composition
QOL
 
12 weeks
 
 
Secondary Outcome  
Outcome  TimePoints 
Body Composition
Quality of Life 
6 weeks 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="7"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Total 120 Subjects will be selected on the basis of selection criteria and will be divided in to FOUR (4) groups equally. 

Group A  Resistance Training (2 times per week continuously for 12 weeks+ Aerobic Training (2 times per week continuously for 12 weeks)

Group B  Resistance Training (4 times/week)

Group C  Aerobic Training (4 times/week)

Group D  Control Group (usual)

 

·         Resisted Training Each exercise session will be for 30 -45 minutes in duration. Each session consisted of a warm-up, a resistance training component and a cool-down phase.

·         Aerobic Training  This group followed a supervised progressive aerobic training program with exercise intensity developing up to 60–75% of heart rate max (HRmax). Subjects workload will be adjusted to achieve 60% of HRmax and 8-9 RPE for 20-30 minutes and  then progressed to 75% of the HRmax and an RPE of 12-13 for up to 60 minutes.

·         Control group  Active control  group will provided standard care during their normal clinic visits to a consultant physician prescribing medication and general health education. There will be no specific instructions given or skills taught regarding exercise nor additional information regarding dietary modifications. The control group also had pre and post intervention measurements of all parameters and background physical activity measurements. This group of participants will contacted via telephone once every 2 weeks during the 12-week period and will  met  in the middle of the intervention (6-7 weeks). If participants wanted to exercise at home during the study or wanted to stop, they were excluded from the study .

 
Close